Meeting Coverage:

EURETINA Congress

EURETINA: 2022

Treating Traumatic Aphakia and Aniridia

Show Description +

Mario R. Romano, MD, PhD, chats with Matteo Forlini, MD, about the treatment options for patients with aphakia and aniridia, including the different artificial iris models available.

Posted: 10/18/2022

Up Next


Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD

Gearing Up for a GA Therapy

Kourous A. Rezaei, MD; and Anat Loewenstein, MD, MHA

Using AI for DR Screening in India

S. Natarajan, MBBS, DO, FICO (UK), FVRS; and Andrzej Grzybowski, MD, PhD, MBA

Steps to Achieving the Impossible in DR Management

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Treating Traumatic Aphakia and Aniridia

Mario R. Romano, MD, PhD, chats with Matteo Forlini, MD, about the treatment options for patients with aphakia and aniridia, including the different artificial iris models available.

Posted: 10/18/2022


Please log in to leave a comment.

More From EURETINA: 2022 Coverage

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD